Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | BCL9 | O00512 | 1/20 | 0.54 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | HTR2A | P28223 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.49 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.49 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.49 |
| ▸ | CES1 | P23141 | 2/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CES2 | O00748 | 1/20 | 0.49 |
| ▸ | MGLL | Q99685 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26374 | 0.88 | GAA (0.65) | GAABCL9CTNNB1KMT2APKM | |
| Hydrochloric Acid SCHEMBL7895043 | 0.86 | GAA (0.62) | GAABCL9CTNNB1KMT2APKM | |
| SCHEMBL3176066 | 0.85 | GAA (0.61) | GAABCL9CTNNB1KMT2APKM | |
| SCHEMBL14378853 | 0.85 | GAA (0.61) | GAABCL9CTNNB1KMT2APKM | |
| SCHEMBL19246046 | 0.83 | GAA (0.59) | GAABCL9CTNNB1KMT2APKM | |
| SCHEMBL1639306 | 0.83 | GAA (0.59) | GAABCL9CTNNB1KMT2APKM | |
| SCHEMBL23084891 | 0.82 | GAA (0.62) | GAABCL9CTNNB1KMT2APKM | |
| SCHEMBL2475075 | 0.81 | BCL9 (0.58) | GAABCL9CTNNB1KMT2APKM | |
| Ethylene Glycol SCHEMBL5476146 | 0.81 | BCL9 (0.58) | GAABCL9CTNNB1KMT2APKM | |
| SCHEMBL6322393 | 0.81 | SMN1; SMN2 (0.64) | GAABCL9CTNNB1KMT2APKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11224663-B2 | Antibody drug conjugates | PHARMA MAR, S.A. (ES) | 2022-01-18 | — | — | US | disclosed |
| EP-3003386-B1 | ANTIBODY DRUG CONJUGATES | PHARMA MAR SA (ES) | 2019-10-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11224663-B2 | Antibody drug conjugates | CD79B, OGFR, CD22 | GAA 2083/4885BCL9 356/4885CTNNB1 997/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.